Skip to main content
Top
Published in: Endocrine 3/2010

01-12-2010 | Original Article

Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells

Authors: Chunlei Tian, Fei Ye, Lei Wang, Yuanguo Deng, Yuanxun Dong, Xiaodan Wang, Tongjiang Xu, Ting Lei, Xiongwei Wang

Published in: Endocrine | Issue 3/2010

Login to get access

Abstract

Ghrelin stimulates growth hormone release and cell proliferation, which strongly supports a significant role for this peptide in the control of growth hormone-releasing adenomas function and growth. Nitric oxide can influence the stimulatory effects of ghrelin on growth hormone secretion in growth hormone-releasing adenomas. However, the effect of nitric oxide (NO) on ghrelin-induced cell proliferation and the mechanism of this effect in the adenoma were not clarified. In this study, we observed that ghrelin, at a concentration of 10−9 to 10−6 M, significantly increased BrdU incorporation into rat GH3 cells. A NO donor, S-nitroso-N-acetylpenicillamine (SNAP), blunted basal, and ghrelin-induced cell proliferation. A blocker of NO synthase, Nw-nitro-l-arginine methyl ester hydrochloride (NAME), had no influence on these actions. The activation of extracellular signal-regulated kinase (ERK) 1/2 was examined by western blotting. The results showed that SNAP reduced ghrelin-stimulated ERK1/2 activation but NAME had no influence on this activation. Together, this study indicates that NO inhibited ghrelin-induced cell proliferation by blocking ERK1/2 activation in GH3 cells.
Literature
1.
go back to reference M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Nature 402(6762), 656–660 (1999)CrossRefPubMed M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Nature 402(6762), 656–660 (1999)CrossRefPubMed
3.
go back to reference A.P. Davenport, T.I. Bonner, S.M. Foord, A.J. Harmar, R.R. Neubig, J.P. Pin, M. Spedding, M. Kojima, K. Kangawa, Pharmacol. Rev. 57(4), 541–546 (2005)CrossRefPubMed A.P. Davenport, T.I. Bonner, S.M. Foord, A.J. Harmar, R.R. Neubig, J.P. Pin, M. Spedding, M. Kojima, K. Kangawa, Pharmacol. Rev. 57(4), 541–546 (2005)CrossRefPubMed
4.
go back to reference A.D. Howard, S.D. Feighner, D.F. Cully, J.P. Arena, P.A. Liberator, C.I. Rosenblum, M. Hamelin, D.L. Hreniuk, O.C. Palyha, J. Anderson, P.S. Paress, C. Diaz, M. Chou, K.K. Liu, K.K. McKee, S.S. Pong, L.Y. Chaung, A. Elbrecht, M. Dashkevicz, R. Heavens, M. Rigby, D.J. Sirinathsinghji, D.C. Dean, D.G. Melillo, A.A. Patchett, R. Nargund, P.R. Griffin, J.A. DeMartino, S.K. Gupta, J.M. Schaeffer, R.G. Smith, L.H. Van der Ploeg, Science 273(5277), 974–977 (1996)CrossRefPubMed A.D. Howard, S.D. Feighner, D.F. Cully, J.P. Arena, P.A. Liberator, C.I. Rosenblum, M. Hamelin, D.L. Hreniuk, O.C. Palyha, J. Anderson, P.S. Paress, C. Diaz, M. Chou, K.K. Liu, K.K. McKee, S.S. Pong, L.Y. Chaung, A. Elbrecht, M. Dashkevicz, R. Heavens, M. Rigby, D.J. Sirinathsinghji, D.C. Dean, D.G. Melillo, A.A. Patchett, R. Nargund, P.R. Griffin, J.A. DeMartino, S.K. Gupta, J.M. Schaeffer, R.G. Smith, L.H. Van der Ploeg, Science 273(5277), 974–977 (1996)CrossRefPubMed
5.
go back to reference A.M. Nanzer, S. Kalaf, A.M. Mozid, R.C. Fowkes, M.V. Patel, J.M. Burrin, A.B. Grossman, M. Korbonits, Eur. J. Endocrinol. 151(2), 233–240 (2004)CrossRefPubMed A.M. Nanzer, S. Kalaf, A.M. Mozid, R.C. Fowkes, M.V. Patel, J.M. Burrin, A.B. Grossman, M. Korbonits, Eur. J. Endocrinol. 151(2), 233–240 (2004)CrossRefPubMed
6.
go back to reference A. Secondo, R. Sirabella, L. Formisano, A. D’ Alessio, P. Castaldo, S. Amoroso, P. Ingleton, G. Di Renzo, L. Annunziato, J. Neurochem. 84(6), 1367–1377 (2003)CrossRefPubMed A. Secondo, R. Sirabella, L. Formisano, A. D’ Alessio, P. Castaldo, S. Amoroso, P. Ingleton, G. Di Renzo, L. Annunziato, J. Neurochem. 84(6), 1367–1377 (2003)CrossRefPubMed
7.
go back to reference M. Murata, Y. Okimura, K. Iida, M. Matsumoto, H. Sowa, H. Kaji, M. Kojima, K. Kangawa, K. Chihara, J. Biol. Chem. 277(7), 5667–5674 (2002)CrossRefPubMed M. Murata, Y. Okimura, K. Iida, M. Matsumoto, H. Sowa, H. Kaji, M. Kojima, K. Kangawa, K. Chihara, J. Biol. Chem. 277(7), 5667–5674 (2002)CrossRefPubMed
9.
go back to reference C.G. Chamberlain, K.J. Mansfield, A. Cerra, Mol. Vis. 14, 983–991 (2008)PubMed C.G. Chamberlain, K.J. Mansfield, A. Cerra, Mol. Vis. 14, 983–991 (2008)PubMed
10.
go back to reference B.H. Duvilanski, C. Zambruno, A. Seilicovich, D. Pisera, M. Lasaga, M.C. Diaz, N. Belova, V. Rettori, S.M. McCann, Proc. Natl Acad. Sci. USA 92(1), 170–174 (1995)CrossRefPubMed B.H. Duvilanski, C. Zambruno, A. Seilicovich, D. Pisera, M. Lasaga, M.C. Diaz, N. Belova, V. Rettori, S.M. McCann, Proc. Natl Acad. Sci. USA 92(1), 170–174 (1995)CrossRefPubMed
11.
go back to reference R. Volpi, P. Chiodera, G. Caffarri, P.P. Vescovi, L. Capretti, C. Gatti, V. Coiro, Neuropeptides 30(6), 528–532 (1996)CrossRefPubMed R. Volpi, P. Chiodera, G. Caffarri, P.P. Vescovi, L. Capretti, C. Gatti, V. Coiro, Neuropeptides 30(6), 528–532 (1996)CrossRefPubMed
12.
go back to reference F. Rodríguez-Pacheco, R.M. Luque, M. Tena-Sempere, M.M. Malagón, J.P. Castaño, J. Neuroendocrinol. 20(3), 406–412 (2008)CrossRefPubMed F. Rodríguez-Pacheco, R.M. Luque, M. Tena-Sempere, M.M. Malagón, J.P. Castaño, J. Neuroendocrinol. 20(3), 406–412 (2008)CrossRefPubMed
13.
go back to reference H.P. Chen, L. Zhang, B.H. Xu, L.M. Kang, S.L. Yang, H.H. Zeng, X.Y. Shi, Tissue Cell 41(2), 133–140 (2009)CrossRefPubMed H.P. Chen, L. Zhang, B.H. Xu, L.M. Kang, S.L. Yang, H.H. Zeng, X.Y. Shi, Tissue Cell 41(2), 133–140 (2009)CrossRefPubMed
14.
15.
go back to reference A. Secondo, A. Pannaccione, M. Cataldi, R. Sirabella, L. Formisano, G. Di Renzo, L. Annunziato, Am. J. Physiol. Cell Physiol. 290(1), 233–243 (2006)CrossRef A. Secondo, A. Pannaccione, M. Cataldi, R. Sirabella, L. Formisano, G. Di Renzo, L. Annunziato, Am. J. Physiol. Cell Physiol. 290(1), 233–243 (2006)CrossRef
16.
go back to reference M. Candolfi, G. Jaita, V. Zaldivar, S. Zarate, D. Pisera, A. Seilicovich, Neuroendocrinology 80(2), 83–91 (2004)CrossRefPubMed M. Candolfi, G. Jaita, V. Zaldivar, S. Zarate, D. Pisera, A. Seilicovich, Neuroendocrinology 80(2), 83–91 (2004)CrossRefPubMed
17.
go back to reference M. Volante, E. Allia, P. Gugliotta, A. Funaro, F. Broglio, R. Deghenghi, G. Muccioli, E. Ghigo, M. Papptti, J. Clin. Endocrinol. Metab. 87(3), 1300–1308 (2002)CrossRefPubMed M. Volante, E. Allia, P. Gugliotta, A. Funaro, F. Broglio, R. Deghenghi, G. Muccioli, E. Ghigo, M. Papptti, J. Clin. Endocrinol. Metab. 87(3), 1300–1308 (2002)CrossRefPubMed
19.
20.
go back to reference C.M. Cuttica, M. Giusti, L. Bocca, P. Sessarego, D. De Martini, S. Valenti, R. Spaziante, G. Giordano, Neuroendocrinology 66(6), 426–431 (1997)CrossRefPubMed C.M. Cuttica, M. Giusti, L. Bocca, P. Sessarego, D. De Martini, S. Valenti, R. Spaziante, G. Giordano, Neuroendocrinology 66(6), 426–431 (1997)CrossRefPubMed
21.
22.
go back to reference M.S. Kim, C.Y. Yoon, P.G. Jang, Y.J. Park, C.S. Shin, H.S. Park, J.W. Ryu, Y.K. Pak, J.Y. Park, K.U. Lee, S.Y. Kim, H.K. Lee, Y.B. Kim, K.S. Park, Mol. Endocrinol. 18(9), 2291–2301 (2004)CrossRefPubMed M.S. Kim, C.Y. Yoon, P.G. Jang, Y.J. Park, C.S. Shin, H.S. Park, J.W. Ryu, Y.K. Pak, J.Y. Park, K.U. Lee, S.Y. Kim, H.K. Lee, Y.B. Kim, K.S. Park, Mol. Endocrinol. 18(9), 2291–2301 (2004)CrossRefPubMed
23.
go back to reference J. S. Gutkind, Sci. STKE. 2000(40), re1 (2000) J. S. Gutkind, Sci. STKE. 2000(40), re1 (2000)
24.
go back to reference H. Maekawa, K. Iwabuchi, I. Nagaoka, H. Watanabe, T. Kamano, M. Tsurumaru, Inflamm. Res. 49(10), 541–547 (2000)CrossRefPubMed H. Maekawa, K. Iwabuchi, I. Nagaoka, H. Watanabe, T. Kamano, M. Tsurumaru, Inflamm. Res. 49(10), 541–547 (2000)CrossRefPubMed
25.
go back to reference G.H. Xue, J.W. Zhang, L. Zhang, H. Zhang, B.G. Zhang, Zhonghua Wai Ke Za Zhi 42(22), 1349–1352 (2004)PubMed G.H. Xue, J.W. Zhang, L. Zhang, H. Zhang, B.G. Zhang, Zhonghua Wai Ke Za Zhi 42(22), 1349–1352 (2004)PubMed
26.
go back to reference D. Maulik, Q.M. Ashraf, O.P. Mishra, M. Delivoria-Papadopoulos, Neurosci. Lett. 439(1), 94–99 (2008)CrossRefPubMed D. Maulik, Q.M. Ashraf, O.P. Mishra, M. Delivoria-Papadopoulos, Neurosci. Lett. 439(1), 94–99 (2008)CrossRefPubMed
27.
go back to reference I. Valverde, A. Penalva, E. Ghigo, F.F. Casanueva, C. Dieguez, Neuroendocrinology 74(4), 213–219 (2001)CrossRefPubMed I. Valverde, A. Penalva, E. Ghigo, F.F. Casanueva, C. Dieguez, Neuroendocrinology 74(4), 213–219 (2001)CrossRefPubMed
29.
go back to reference D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, D.A. Wink, Biol. Med. 45(1), 18–31 (2008) D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, D.A. Wink, Biol. Med. 45(1), 18–31 (2008)
Metadata
Title
Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells
Authors
Chunlei Tian
Fei Ye
Lei Wang
Yuanguo Deng
Yuanxun Dong
Xiaodan Wang
Tongjiang Xu
Ting Lei
Xiongwei Wang
Publication date
01-12-2010
Publisher
Springer US
Published in
Endocrine / Issue 3/2010
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9402-9

Other articles of this Issue 3/2010

Endocrine 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.